CorMedix
CRMD
57 hedge funds and large institutions have $27.7M invested in CorMedix in 2015 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 3 closing their positions.
867% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 3
633% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 3
84% more funds holding
Funds holding: 31 → 57 (+26)
1.19% more ownership
Funds ownership: 3.41% → 4.59% (+1.2%)
32% less capital invested
Capital invested by funds: $40.4M → $27.7M (-$12.8M)
87% less call options, than puts
Call options by funds: $615K | Put options by funds: $4.68M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.24M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.1M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.64M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.28M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.53M |
| 3 |
Renaissance Technologies
New York
|
-$468K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$166K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$115K |
CRMD Hedge Fund Activity: Q2 2015 in Review
57 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2015, worth a combined $27.7M — down 32% from $40.4M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new CRMD positions and 3 closed out — a net gain of 26 holders — while 22 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $5.24M. The largest seller was Millennium Management, cutting an estimated $2.28M.
- 57 institutional investors held CorMedix (CRMD) as of Q2 2015, up from 31 in Q1 2015.
- Funds reported $27.7M of CorMedix stock for Q2 2015, down 32% quarter-over-quarter.
- 29 funds opened new CorMedix positions in Q2 2015 and 3 closed out, a net change of +26 holders.
- The largest CorMedix buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $5.24M added.
- The largest CorMedix seller in Q2 2015 was Millennium Management, an estimated $2.28M sold.
Based on aggregated 13F filings for Q2 2015.